Cell and Gene Therapy

CDMO News

CCRM to Evaluate Avectas Cell Therapy Manufacturing Platform with OmniaBio

16 June 2026

Content

IPSC Manufacturing: The 30-Year Journey From Dolly the Sheep to Clinical-Grade Cell Therapies

30 April 2026

Expert Insight

Why AAV Programs Fail to Scale and What Academics Need to Do Differently

27 March 2026

Expert Insight

What Cell Therapy Biotechs Get Wrong When Selecting a CDMO

25 March 2026

Expert Insight

What Goes Wrong When Cell and Gene Therapy Programs Move From Clinic to Commercial

24 March 2026

Content

Middle East Airspace Closures Are Redirecting Vital Cell Therapies Away From Cancer Patients

20 March 2026

Content

Biotech CMC: Scaling Gene Therapy for Longevity

5 March 2026

Biotech Profile

From Lab to Patient: How Tetraneuron’s Gene Therapy Approach is Tackling Alzheimer’s Disease

4 August 2025

Podcast

The Promise of Cell & Gene Therapy to Reshape Healthcare, with Devyn Smith, CEO Arbor Biotech

20 December 2024

Podcast

How Cell and Gene Therapy can overcome the ‘Hubris of Science’ – Accenture’s Sanjay Srivastava

20 September 2024